M. Wagner, M. Goetghebeur, E. Merikle, A. Pandya, P. Chu, and D. C. Taylor, “COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA”, J Popl Ther Clin Pharmacol, vol. 16, no. 2, Dec. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/549